The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the results after treating a case of severe asthma with nasal polyps: "After five months of starting Dupilumab frequency of ...

18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab ... year – has been welcomed by Asthma UK and the British Lung Foundation Partnership ...

A highly effective drug for a debilitating lung disease is set to become the first new treatment for the condition in more ...

Read these and more top stories in allergy/asthma below: Dupilumab does not desensitize children with peanut allergy Following receipt of dupilumab for 24 weeks, most children or adolescents with ...